Efficacy and Safety of Filgotinib in Adults With Active Noninfectious Uveitis
Status:
Terminated
Trial end date:
2021-04-22
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of filgotinib versus placebo
for the treatment of the signs and symptoms of noninfectious uveitis in participants failing
treatment for active noninfectious uveitis.